"10.1371_journal.ppat.1003691","plos pathogens","2013-10-10T00:00:00Z","Hiroyu Hatano; Steven A Yukl; April L Ferre; Erin H Graf; Ma Somsouk; Elizabeth Sinclair; Mohamed Abdel-Mohsen; Teri Liegler; Kara Harvill; Rebecca Hoh; Sarah Palmer; Peter Bacchetti; Peter W Hunt; Jeffrey N Martin; Joseph M McCune; Russell P Tracy; Michael P Busch; Una O'Doherty; Barbara L Shacklett; Joseph K Wong; Steven G Deeks","Department of Medicine, University of California San Francisco, San Francisco, California, United States of America; Department of Medicine, San Francisco Veterans Affairs Medical Center, San Francisco, California, United States of America; Department of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, Davis, California, United States of America; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America; Karolinska Institutet and Swedish Institute for Infectious Disease Control, Solna, Sweden; Centre for Virus Research, Westmead Millennium Institute and University of Sydney, Westmead, Australia; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, United States of America; Departments of Pathology and Biochemistry, University of Vermont, Colchester, Vermont, United States of America; Blood Systems Research Institute, San Francisco, California, United States of America; Department of Laboratory Medicine, University of California San Francisco, San Francisco, California, United States of America","Conceived and designed the experiments: HH. Performed the experiments: SAY MAM TL JKW ALF BLS EHG UO ES JMM SP RPT MPB. Analyzed the data: HH PB. Contributed reagents/materials/analysis tools: JKW BLS UO MS PWH JMM SP JNM MPB SGD. Wrote the paper: HH. Recruited and enrolled study subjects: HH KH RH. Edited the manuscript: HH SAY ALF EHG MS ES MAM TL KH RH SP PB PWH JNM JMM RPT MPB UO BLS JKW SGD.","HH and SGD have received research support from Merck, Inc., and Gilead, Inc. UO has received research support from Merck, Inc. SAY, ALF, EHG, MS, ES, MAM, TL, KH, RH, SP, PB, PWH, JNM, JMM, RPT, MPB, BLS, and JKW have no conflicts to declare. The study drug was provided by Merck, Inc., and Gilead, Inc., at no cost to this study. Reagents were provided by Gen-Probe/Hologic and Ortho Clinical Diagnostics at no cost to this study. This does not alter our adherence to all PLoS Pathogens policies on sharing data and materials.","2013","10","Hiroyu Hatano","HH",21,TRUE,1,13,2,1,TRUE,TRUE,FALSE,0,NA,FALSE
